Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-26

Clinical Trial Update: Dutasteride in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating dutasteride for treating prostate cancer. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

Sponsor: University College London Hospitals | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN